Cipher PharmaceuticalsCipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products ProductsPipeline NewsCipher Pharmaceuticals Announces Normal Course Issuer Bid August 12, 2020Cipher Pharmaceuticals Reports Second Quarter 2020 Financial Results August 12, 2020Events Q1 2020 Results Conference Call/Webcast Friday, May 8, 2020 Webcast Replay Investors Financial Reports Investor Presentation Corporate Governance Documents Webcasts
